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>PIIIODI 
Our cover story: The importance of 
being earnest about taking HIV drugs. 
>PIIIIWO 
By The Way: Editor Mike Martin's 
monthly meanderings. 
>Pauelhree 
Short takes: HIV News in Review. 
>Pauetour 
TAP Support Groups. 
The TAP List of People. 
All here in this April edition of 
In The Affirmative. 
The good folk6 at Peabody 
Hou6e are 6pon6oring a celebration 
of Frannie Peabodys 95th birthday. 
The public i6 invited to join the 
celebration, which will be held on 
Sunday, April 1 9, 1998, at the 
Portland Mu6eum of Art from 7:00 
to9:00p.m. 
Cake, ice cream, a tribute to 
Frannie, and a performance by the 
Maine Gay Mens Choru6 will be 
6erved up in honor of thi6 great 
ladys birthday. 
Come and join the fun and help 
make thi6 a 6pectacular evening. 
Contact Peabody Hou6e at 
77 4-6281 for more info. 
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Editors note: The following article appeared in the newsletter Maine AIDS Care, published by the AIDS 
Consultation Service (ACS) of Maine Medical Center. It is written for physicians caring for people with 
HIV/ AIDS and talks about the importance of patients taking their HIV medicines as prescribed, meaning taking 
the right doses at the right time all the time. This is an issue of great importance to people with HIV; also, it is 
interesting to read the advice given to physicians who care for people with HIV/AIDS by the A CS, one of whose 
jobs it is to stay on top of HIV treatment issues. 
The level of compliance with antiretroviral drug regimens can have a dramatic effect on the success of the 
treatment. Patients who are compliant with at 
least 90% of their antiviral medications had the 
best chance of achieving dramatic and long-
term viral suppression, while those who 
missed more than 10% of their medications 
clearly had less success. There are few other 
illnesses that have such dramatic conse-
quences in terms of talcing medications 
correctly or incorrectly. 
The safest way to use antiretroviral drugs 
is to take all doses or, if there are any problems, 
to stop taking the drugs completely. 
Intermittent dosing, or missing one or two 
doses per day, is the worst approach and is 
associated with a high risk of causing 
resistance to treatment. 
Several factors influence compliance. 
The simplicity of the treatment regimen has a 
major impact. Compliance increases when 
treatments are given once or twice instead of 
three or four times daily. The patient's 
perception of the severity of their illness is 
another important factor. People who 
understand that HIV is a serious illness with 
serious consequences may be more likely to be 
compliant than those who in their denial view 
their illness less seriously. The side effects of 
the regimens are also important. People talcing 
these regimens must understand that many 
side effects are transient and can be managed. 
Also, people who have contact with peers who 
are taking the regimens successfully may be 
more likely to adhere to their own regimens. 
Consistency of dosing is important. The 
emergence of resistance is much more likely in 
a person who takes less-than-adequate 
amounts of drugs than in a person who stops 
talcing the drugs entirely. Without the presence 
of the drugs, there is little reason for the virus 
to develop resistance. 
e resistance to a articular prote.:i:;e 
inhibitor occurs, it is very 1 1c t to 
overcome that resistance by increasing the 
drug dosage. J.tam,ears that once the eff~tive-
ness of a drug is gone, it 1s gone for gQ9d. The 
other issue is cross resistance to other protease 
inhibitors. Patients who develop resistance to 
~tease are less likely to respond fully tq_ 
others. 
- There are some ways to try and maximize 
compliance. Have several discussions with the 
patient before starting medications. This helps 
both the doctor and the patient assess the 
likelihood that they can stay on the necessary 
schedule and dosage. Go through a typical day, 
hour by hour, and tell the patient exactly which 
meds to take at what time each day. Write it 
down for them so that they can see the details. 
Make the schedule personalized to the times 
they wake up, go to sleep, eat their meals, go to 
work,etc. 
Also spend time discussing the risk for 
side effects, and what to expect regarding them 
l
. lasting, diminishing, or being managed; and 
talk about how to manage them. 
Ongoing reinforcement is also essential. 
Do follow up calls, provide coaching, and 
monitor their compliance by having them keep 
a log, do pill counts, etc. 
Finally, it is important to tailor treatment 
recommendations to the patient's likelihood of 
compliance. It might be better to use a less 
taxing regimen, rather than risk resistance to 
the regimen that technically might hit the virus 
the hardest. Discuss all options with the patient 
and make the decision collaboratively. This 
will bring you a better chance for success. • 
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An important reminder to clients: 
There are funds available to TAP clients 
with financial need for the following 
items: 
Routine Dental Care, Routine Eye ·care 
and Eyeglasses, Vitamin Supplements, 
Non-Prescription Skin Care Products, 
and Non-Medicaid Medication Co-pays. 
There is a dollar limit to how much an 
individual client can receive in any fiscal 
year. Contact your case manager for 
assistance by calling TAP. 
.1.111111 
s1111n 1r111 11d111 
Meetings for the I. V. League 
support group are: 
Wednesdays, 8:00 to 9:30 a.m., 
Discovery House, Portland. 
Wednesdays, 6:30 to 8:00 p.m., 
Community Resource Center, Portland. 
Contact the City of Portland Public 
Health Division at 756-8257. 
Iha AIDS 1r1iac1·s 
mailing address 
When writing to The AIDS Project in 
Portland, please send your mail 
to our post office box. 
It really rushes mail delivery if letters 
are not addressed to our street address, 
so write us at: 
P. 0. Box 5305 
Portland, ME 04101 
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T he clocks have been turned back and the snow is gone. It feels a lot like spring to me. It is a new season 
of hope. (And I am hoping we don't have 
one last surprise snow storm!) 
Ten years ago this month I tested 
positive for HIV. It seems a long time ago, 
yet not so very long ago that I can't 
remember the details. I remember my 
doctor having a couple of tears in his eyes 
when he told me the results. I remember 
my doctor setting up an appointment for 
me with Dr. Michael Bach. I remember 
the shock of it all, but not being surprised. 
I remember thinking I would die in the 
not-too-distant future, probably of some 
horrible opportunistic infection. I 
remember the determination on my 
mother's face when she told me she didn't 
think I would die from AIDS. She had a 
sense of hope that was hard for me to 
relate to, yet here I am ten years later. 
Along the way from there to here, 
I've met a lot of great people. People with 
HIV/AIDS, and people who care about 
people with HIV/AIDS. I'd just like to 
talk about two of them. 
First is Steve Schuit. Steve was on the 
Nominating Committee when I inter-
viewed to be on the Board of The AIDS 
Project two and a half years ago. Due to 
his family, business, and volunteer work, 
Steve just resigned from TAP's Board. I'll 
miss his presence on the Board because he 
is an exceptional person. He is the kind of 
guy who sees a problem or a conflict and 
immediately starts thinking of ways to 
resolve it. He has served TAP well 
through his work on different committees 
of the Board, such as Personnel and 
Search. His ability to really listen and then 
brainstorm solutions is something I try to 
emulate. We ' ll miss him at Board 
meetings. Thanks, Steve, for all your 
good work. 
Second, but not least, I'd like to talk 
about Tamara Harvey. She is leaving TAP 
this month. Tamara has been an adminis-
trative assistant/development assistant 
during her time at TAP. She, too, is an 
exceptional person. She has a kind heart, a 
sweet voice, an agile mind, and she gives 
great hugs. She came to TAP in a time of 
need and has fulfilled that need admirably. 
Tamara has proofread every issue of 
In The Affirmative since she arrived. We 
share the knowledge that no matter how 
careful we both are in putting the newslet-
ter together, we always end up with at 
least one mistake. The world is not perfect 
and neither are we. I've always appreci-
ated the time and effort she has put into 
this newsletter. It won't be the same 
without her. 
And she has done phenomenal work 
in the Development Office. The success 
of TAP's fundraising is very much a 
reflection of the countless hours she has 
put in. The recent success of the Art 
Auction is a tribute to her fine work. 
As she proofreads this last newsletter, 
let me just say to her, "Love ya, darling." 
On the front page of this month's 
newsletter is an article on the importance 
of people with HIV/AIDS to take their 
drugs compliantly. It is an issue so very 
important because of the virus' ability to 
develop resistance to the various drugs if 
they are not taken correctly. And drug 
resistance is not good. 
Recently, I spoke at Southern Maine 
Technical College with Sandy Putnam of 
the ACS and two other folks like myself 
with HIV. We spoke to a nursing class 
about the treatments for HIV and our own 
experiences being HIV-positive. In the 
first part of the morning, Sandy spoke 
alone and I listened intently as she told the 
nursing students about the risks of drug 
resistance if patients are not compliant in 
taking their meds. In particular, she spoke 
of the knowledge that resistance to one 
protease inhibitor could well mean 
resistance to all other protease inhibitors. 
Compliance in taking these meds, and 
other HIV drugs, Sandy said, is very, very 
important. 
As you will read in the article on the 
front page, it is now accepted that it is 
better not to take these drugs than to take 
them improperly. While just a short while 
ago protease inhibitors were being handed 
out like candy (my words, not Sandy's), 
doctors are more carefully assessing who 
should take them, based in part on a 
person's ability to follow the schedule and 
dosing requirements. It truly is a case of 
"if you' re going to do something, do it 
right! " 
We all want to live a long life. Perhaps 
as long as Frannie Peabody, who turns 95 
this month. The folks at Peabody House 
are throwing her a very public birthday 
party, the details of which appear else-
where in this newsletter. So, happy 
birthday to you, Frannie. We love you 
very much. And thanks for all you do for 
peoplewithHJV/AIDS .• 
The first case to involve HIV/AIDS has 
been heard by the U.S. Supreme Court. It 
involves a Bangor dentist who refused to fill a 
HIV-positive woman's tooth cavity in his office, 
saying he would only do the procedure in a 
hospital. The woman sued for discrimination 
under the American With Disabilities Act. The 
justices could rule anytime before the court 's 
term ends in late June or early August. 
l;he ~u;ecommended using 
a new lrrvtest that givesresults instantly rather 
than a week later. Under current testing, nearly 
700,000 of the 2 million people in the U.S . who 
get tested each year do not return for their results. 
The new test takes about ten minutes and, it is 
hoped, will eliminate the loss of those 700,000 
non-returnees. Since it is estimated that there 
would be about 8,000 people who receive false-
positive results, (meaning the test says they are 
HIV infected, but they really are not) the more 
traditional blood test will be done on anyone 
testing HIV-positive to verify the diagnosis. 
A majority of blacks consider AIDS the 
nation's most pressing health problem. AIDS is 
the leading cause of death in black men and 
women between the ages of 25 and 44. Forty 
percent of all new AIDS cases are among blacks, 
while they make up only 12 percent of the 
population. Annual AIDS cases in black men is 6 
times higher than in white men. 
You can take some foods with the drug 
Crixivan, so says Merck, the company that 
makes the drug. However, the food cannot 
exceed 65 grams of carbohydrates, 5. 7 grams of 
protein, 2 grams of fat, or 301 calories. Some 
suggested snacks for folks who don 't tolerate 
Crixivan well without food are: 
2 fig bars and I cup of juice; 
or 1/2 cup of dry cereal with I /2 cup of skim 
milkanda 1/2ofabanana; 
or I English muffin or toast and I table-
spoon of jam (no butter!), 1 cup tea or coffee with 
2 tsp. of sugar; 
or I com tortilla, 1/2 cup of steamed rice, 
and 3 tablespoons of salsa. 
Global health experts are trying to work 
out a strategy for giving AZT to HIV-infected 
mothers-to-be in the developing world. Last 
month the U.N. reported that giving the drug to 
HIV-infected pregnant women for the last month 
of their pregnancy and during birth can cut virus 
transmission by 51 %. It is estimated that 2 
million women carrying the virus will become 
pregnant this year in the developing world. 
Without AZT treatment, it is estimated that 
400,000 HIV-positive infants will be born. With 
AZT treatment, half ( or 200,000) of the babies 
would be spared infection. 
Early tracking of HIV aimed at identifying 
people in the earliest stages of infection is being 
debated across the country. The CDC may make 
recommendations on tracking individuals who 
are HIV-positive in the next few months, 
possibly tying tracking compliance to federal 
funding. Currently, most states only require 
reporting of people who have an AIDS diagno-
sis. 
Most AIDS groups and the ACLU are on 
record as opposing name-based tracking while 
some AIDS groups endorse tracking by either 
numbers or codes. Part of the emphasis on early 
reporting is the change in treatment options for 
HIV. It is now recommended that treatment begin 
as early as possible; and health officials want to 
reach the newly diagnosed to make sure they are 
aware of treatment options. 
There is great concern over the confidential-
ity of any tracking system, and some argue that 
any HIV tracking would be low because as many 
as half of the people in this country who are 
infected with HIV haven't been tested or don't 
know their status. 
The York County AIDS Network 
(YCAN) announced it has abandoned its goal to 
create rotating anonymous HIV testing sites in 
York County. YCAN is a collaborative team of 
people from many York County agencies, and 
they will continue to provide services and care 
for people with HIV and AIDS. There are 
currently only two anonymous testing sites in 
York County. They are at the University of New 
England in Biddeford Pool and Planned 
Parenthood in Sanford. 
The Vermont People with HIV/AIDS 
Coalition with sponsor a retreat for people with 
HIV/AIDS in Plainfield, Vermont from 
Thursday, June 4, to Sunday, June 7. It will be 
their 8th annual gathering. 
Workshops on Social Security, Insurance, 
Acupuncture, Tai Chi, and many other topics will 
take place during the retreat, which is entitled 
"Turning Hope Into Action." 
For more information contact the VTPWA 
Coalition at P.O. Box 11, Montpelier, VT05601-
0011 or call them (in Vermont only) at 1-800-
698-8792 or (elsewhere) at 1-800-229-5754. The 
cost of the retreat is $75. 
There is confusion around the issue of 
when to stop taking drugs meant to prevent 
opportunistic infections. Now that many people 
with HIV are seeing increased T-cell counts due 
to triple combination therapies, doctors are not 
sure if it is OK to stop taking drugs meant to 
prevent opportunistic infections and that were 
started when T-cell counts had dropped to those 
levels where the CDC recommends prophylaxis 
drugs. There are cases of people getting 
opportunistic infections such as CMV, PCP, and 
MAC (among others) with T-cell counts 
previously thought to be too high for people to 
worry about. Studies are being done, but are not 
completed. Until then, the current recommenda-
tion is to continue using preventative treatments 
based on the lowest T-cell count a patient has 
had. 
lhe 1needn1 qlac 
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This room is used by TAP in Portland 
for support groups, counseling and 
testing, and some client/case manager 
meetings. Located in Suite 632, it 
provides more privacy for people served 
by TAP. Enter from the High Street side 
of the building. 
AIDS hotllnes 
Questions about HIV? Call toll-free 
National AIDS Hotline: 1-800-342-2437 
Maine AIDSline: 1-800-851-2437 
Maine Teen Hotline: 1-800-851-2437 
(on Wednesdays from 6-9pm) 
tap on the Internet 
Visit our address at: 
"www.aidsproject.org" 
To e-mail The AIDS Project, 
send your message along to 
"tap@aidsproject.org" 
1111nedlate seauna 
For free tickets to area events as they 
become available, sign up with Robert 
for "Immediate Seating." Robert can be 
contacted directly on Friday afternoons 
by calling TAP at 774-6877, or you can 
call other times during the week and 
leave a message for him. 
tree lunch 
Enjoy a free lunch at The AIDS Project 
every Thursday at noon. Join other 
clients and TAP staff for a great meal, 
fun conversation, and good company. 
Bald Man Publishing ©April 1998 
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for people 
infected and affected 
by HIV/AIDS 
Time: 10:30 a.m. to noon 
Group: HIV lnfeded/Affeded Drop-In Support 
Group 
A meeting for people living with and affected by the virus . 
Location: Portland, TAP, The Meeting Place, Suite 
632. Contact Randy May at TAP at 77 4-6877 for more 
information. 
Time: 1 :00 p.m. to 2:30 p.m. 
Dates: 2nd and 4th Tuesdays 
Group: Women's Drop-In Support Group 
A bi-weekly meeting of women living with HIV /AIDS or directly 
affected by the disease (through spouse/ partner, parent, or 
child). Sponsored by TAP and The AIDS Consultation Service 
(ACS) at Moine Medical Center. 
Location: Portland, ACS, 52 Giiman Street. Contact 
Janine Collins at TAP at 77 4-6877 or Cindy Luce at ACS at 
871-2991 for more information. 
Time: 1 :30 p.m. to 3:00 p.m. 
Group: People Living with HIV 
An ongoing drop-in support group for people living with HIV 
Location: Auburn, TAP, One Auburn Center. Contact 
Diano Corrigan at TAP at 783-4301 for more information. 
llhursdavs 
Time: 10:00 a.m. to 11 :30 a.m. 
Group: HIV lnfeded/Affeded Drop-In Group 
A TAP-sponsored meeting for people infected and affected by 
HIV/ AIDS in southem Moine. 
Location: Sanford, Unitarian Church, located at the 
comer of Main St. (Rte. 109) and Lebanon St. (Rte. 
202). Contact Getty Payson at TAP at 985-8199 for more 
information. 
Time: 12noon 
Group: Open Lunch for TAP Clients/Staff 
An informal luncheon gathering ofTAP staff and clients. 
Location: Portland, TAP, Conference Room. Contact 
Rondy Moy at TAP at 77 4-6877 for more information. 
Time: 5:30 p.m. to 7:00 p.m. 
Group: People Living with HIV /AIDS 
A drop-in supportgraupforonyonewith HIV/ AIDS. 
Location: Portland, TAP, The Meeting Place, Suite 
632. Contact Rondy May at TAP at 77 4-6877 for more 
information. 
Wellness and You •. 
.. .is a collaborative fitness program 
from The AIDS Project and the 
University ofNew England. 
For information on how to join, 
contact your case manager at The AIDS 
Project. 
Ed Shannon has sent along some of 
comments made by the participants of 
the Wellness and You program. So here 
are some -- usually desperate and 
sometimes memorable -- quotes (with 
the names changed to protect the 
healthy). 
"Judy, I can i do this. I hate getting 
up in the morning anyway. And besides, 
my morning big head and big hair takes 
too much time to brush out. " 
"Monte, I can i do this. Since my 
PCP I kinda look like Mr. Potato Head. 
Stick arms and legs and a big belly. No 
way! I can i ever look good. Not like 
when I used to look sooooo ... good!" 
"You know, after my workout the 
other day, I felt kinda like my whole 
body got a good flushing. That familiar 
clogged up feeling is all gone. " 
"Hey, are these my abs? If they are, 
it 'II be the first time in IO years since 
I've seen them. " 
The Wellness and You program just 
might be for you. Check it out. Call your 
case manager! 
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In The Affirmative is a monthly newsletter published by 
The AIDS Project for people living with and affected by 
IUV/AIDS. Letters, articles, or other submissions should 
be sent to: In The Affirmative, clo The AIDS Project, P.O. 
Box 5305, Portland, ME 04101, or call (207) 77~77. 
Submissions can be printed anonymously as long as the 
person submitting the material Includes bis or her name 
and phone number for verification. 
News, Information, and features are as up-to-date as 
possible prior to publication. Any medical information 
included In this newsletter is submitted for the reader's 
Information only, to be used as the reader so chooses. 
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